HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy.
- SemaglutideFrom $199/mo
- TirzepatideFrom $299/mo
Assume we may earn a commission, at no cost to you. Partners we work with carry a small, fixed edge in where they are listed; the scores themselves are not adjusted.
- Semaglutide
- From $199/mo (all doses, compounded)
- Tirzepatide
- From $299/mo (all doses, compounded)
- Coverage
- All 50 states
- Brand-name
- Compounded only
The scorecard
HealthSource scored on our six published factors. See the methodology.
What we like
- Three GLP-1 options: compounded semaglutide injection, tirzepatide injection, and oral sublingual tirzepatide
- 24/7 access to care team via HIPAA-compliant platform with unlimited physician messaging
- Every program covers the cost of medication, supplies, and telehealth visits — no separate pharmacy fee
- Subscription auto-refund if monthly reassessment is not completed
- Available in all 50 US states including Alaska and Hawaii with 3–5 day shipping
The caveats
- No physician names or clinical leadership disclosed on public pages
- No LegitScript certification found
- 503A partner pharmacy not named — less transparent than providers disclosing their 503B pharmacy
- Labs not mentioned on any product page — baseline bloodwork protocol unknown
- WooCommerce e-commerce storefront may feel more transactional than clinical
The verdict
Best for: Shoppers who want compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo.
Ranked #64 of 548 providers we have reviewed — for comparison, read our CoreAge Rx review, ranked #1. In the ranking it sits between Curve at #63, 77/100 above and Intimate Rose at #65, 77/100 below, with the Medro write-up the next one down.
A grade C is a ranking, not an instruction to stop looking: the closest rivals to HealthSource are scored on the identical rubric, so the comparison is like for like. For the wider picture, every review we have published ranks the field on the same six factors. We have also compared it head to head: CoreAge Rx vs HealthSource goes to CoreAge Rx, 94/100 to 77/100.
Compare HealthSource
Compare with other providers
The closest reviews to HealthSource by Verdict Score — the realistic shortlist if you are weighing this one up.
- #46FitFlow— Online access to compounded semaglutide and tirzepatide, with monthly billing or discounted prepaid plans.79/100
- #47Nalena— Nalena is a women-focused, GLP-1-only telehealth platform offering compounded semaglutide and tirzepatide with medication included — no separate membership or visit fees.79/100
- #48Polly— Telehealth weight loss provider selling compounded semaglutide and tirzepatide vials with no membership fee.79/100
- #49Bodybuilding Health+— The Bodybuilding.com fitness brand's new compounded-telehealth arm publishes both ladders in full, and they run in opposite directions: semaglutide steps down from $179/mo to $139/mo on a 12-month prepay, while every tirzepatide bundle costs MORE per month than its $209 month-to-month rate — $286, $250 and $244 — with each badged as a saving. Wrapped in an unusually deep NAD+/sermorelin/peptide menu, but the verdict lands it near the bottom: a brand-new operator (Dynamo Group LLC, launched April 2026) selling compounded, not-FDA-approved meds on an all-sales-final policy, with the pharmacy and provider network unnamed on-site and no LegitScript listing we could verify.76/100
- #50Rylo Health— A small Texas-prescriber startup that prints its promotional rate and its standard rate side by side, which few rows here do.78/100
- #51Big Easy Weight Loss— Physician-led compounded GLP-1 care sold as multiweek packages, with pharmacy-dependent pricing and separate introductory offers.78/100
Pricing, states and verification reflect HealthSource's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on HealthSource's site. Not medical advice; see our disclosure.